Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Caroline Charles"'
Autor:
Caroline Charles
Publikováno v:
European Medical Journal Hepatology, Vol 4, Iss 1, Pp 65-68 (2016)
Rifaximin (RFX)-α is a broad-spectrum antibiotic that targets commensal gut bacteria and reduces the excess ammonia produced by the gut bacteria of patients with cirrhosis. This innovative agent has been approved in most European countries for sever
Externí odkaz:
https://doaj.org/article/ed0a65e7acba4862b048114f924e4906
Publikováno v:
European Medical Journal Urology, Vol 3, Iss 2, Pp 90-102 (2015)
Externí odkaz:
https://doaj.org/article/23be85bf03e24c329e9dc4511ce8ad6f
Publikováno v:
European Medical Journal Gastroenterology, Vol 3, Iss 1, Pp 36-41 (2014)
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that affects up to 15% of the European and North American population, and is characterised by abdominal pain, bloating sensations, cramping, constipation, and diarrhoea. Main subtyp
Externí odkaz:
https://doaj.org/article/922df3a4925644e3b8f20660b213f784
Publikováno v:
European Medical Journal Neurology, Vol 2, Iss 1, Pp 44-48 (2014)
Externí odkaz:
https://doaj.org/article/20de15173e7742d5acd7585bf5519a30
Autor:
Anne Caroline Charles
Publikováno v:
Canadian Journal of Higher Education. 47:191-194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7fd7f03fee64dae2d56d6aee0224182
https://doi.org/10.47678/cjhe.v47i2.188115
https://doi.org/10.47678/cjhe.v47i2.188115
Autor:
Anne Caroline Charles
Publikováno v:
Canadian Journal of Higher Education. 48:154-156
Book review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c3ad89e2af79991bd462e8c34fd6d4
https://doi.org/10.47678/cjhe.v48i1.188188
https://doi.org/10.47678/cjhe.v48i1.188188
Autor:
Caroline Charles
Publikováno v:
European Medical Journal. :76-84
On January 14th 2016, SB4 (Benepali®) received marketing authorisation application approval from the European Commission (EC). It is the first biosimilar to etanercept available in Europe as well as the first subcutaneous anti-tumour necrosis factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02aa6f1094940b75b2dbb0b7c5136b65
https://doi.org/10.33590/emj/10314707
https://doi.org/10.33590/emj/10314707
Bioresorbable Vascular Scaffolds as Optimal Treatment for Selected Patients in our Clinical Practice
Autor:
Caroline Charles
Publikováno v:
EMJ Interventional Cardiology. :2-7
Bioresorbable vascular scaffolds (BRS)/bioabsorbable stents are a new and promising generation of intravascular devices that may potentially circumvent many of the problems associated with permanent metallic stents for coronary artery bypass graft su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7eaf0aee420f4b785c2be918f33c5f6a
https://doi.org/10.33590/emjintcardiol/10314982
https://doi.org/10.33590/emjintcardiol/10314982
Autor:
Caroline Charles
Publikováno v:
EMJ Rheumatology. :2-10
Interleukin (IL)-1 is a messenger for the regulation of inflammatory responses, but it can be harmful when in excess, such as in the inflammation observed in patients with autoinflammatory disease. Cryopyrinassociated periodic syndromes (CAPS) are a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::958bb39d4c398a7020928ee092a07b5e
https://doi.org/10.33590/emjrheumatol/10314940
https://doi.org/10.33590/emjrheumatol/10314940
Autor:
Caroline Charles
Publikováno v:
EMJ Hepatology. :2-19
Rapid developments in clinical research on the hepatitis C virus infection in the last few years have led to the development of direct-acting antivirals, such as sofosbuvir, simeprevir (both of which have been approved in the US and Europe since 2014
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdde506a4ee048709f23bb20e347248b
https://doi.org/10.33590/emjhepatol/10313824
https://doi.org/10.33590/emjhepatol/10313824